Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...

Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty generic drugs ...

Report reveals big pharma middlemen inflating drug prices, reaping billions in excess revenue. • The Federal Trade Commission (FTC) released a report showing that pharmacy benefit managers (PBMs) ...

The drug middlemen known as pharmacy-benefit managers took another body blow from regulators on Tuesday, as they were criticized for charging way more for some “critical” prescription drugs than it ...

Units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged significantly more than the national average ...

The Federal Trade Commission is a government agency that enforces consumer protection and antitrust laws. Consumers can also ...

The Federal Trade Commission suggests that PBMs profit from specialty generic drugs such as those for cancer and HIV and ...

Dec. 17 (UPI) --In a political win for the Biden administration, the Federal Trade Commission on Tuesday approved its final policy rule to ban so-called junk fees for tickets and hotels.

The Federal Trade Commission is investigating Microsoft in a wide-ranging probe that will examine whether the company’s business practices have run afoul of antitrust laws, according to people ...